0.5(top 50%)
impact factor
205(top 50%)
papers
1.3K(top 50%)
citations
8(top 50%)
h-index
0.5(top 50%)
impact factor
3.1K
all documents
1.3K
doc citations
11(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Practical Experience of Using Riamilovir in Treatment of Patients with Moderate COVID-19Antibiotiki I Khimioterapiya202014
2Associated resistance of Escherichia coli isolated from humans and animals to polymyxin and beta-lactam antibioticsAntibiotiki I Khimioterapiya202211
3Clinical Efficiency and Safety of Riamilovir for Treating Patients with SARS-CoV-2 InfectionAntibiotiki I Khimioterapiya202110
4Multicentre Study of the Prevalence and Clinical Value of Hospital-Acquired Infections in Emergency Hospitals of Russia: ERGINI Study TeamAntibiotiki I Khimioterapiya20169
5Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy OptimizationAntibiotiki I Khimioterapiya20208
6Antiviral Activity of Kagocel<sup>®</sup> in vitro Against Virus SARS-CoV-2Antibiotiki I Khimioterapiya20207
7Appointment of Antimicrobial Medications in a Hospital Depending on the Results of Microbiological Monitoring of HAIAntibiotiki I Khimioterapiya20207
8The Efficacy and Safety of Riamilovir in the Treatment of Patients with COVID-19Antibiotiki I Khimioterapiya20216
9The Effectiveness of Antifungal Agents Against Yeasts of Candida Genus Isolated in Moscow RegionAntibiotiki I Khimioterapiya20206
10Antioxidants as Potential Antiviral Agents for Flavivirus InfectionsAntibiotiki I Khimioterapiya20166
11Investigation of Thionins from Black Cumin (Nigella sativa L.) Seeds Showing Cytotoxic, Regulatory and Antifungal ActivityAntibiotiki I Khimioterapiya20166
12Meta-analysis of randomized controlled clinical trials of Riamilovir efficacy in the etiotropic therapy of acute respiratory viral infectionAntibiotiki I Khimioterapiya20215
13Prevalence and Antibiotic Resistance of Carbapenemase-Producing Gram-Negative Bacteria in Saint Petersburg and Some Other Regions of the Russian FederationAntibiotiki I Khimioterapiya20165
14Antibacterial Therapy of Patients With COVID-19 During The Outpatient and Hospital StagesAntibiotiki I Khimioterapiya20225
15An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam<sup>®</sup>-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019)Antibiotiki I Khimioterapiya20214
16Community-Acquired Pneumonia of Bacterial Etiology and the Spectrum of Pathogen Sensitivity to Antibiotics in Corona-Positive and Corona-Negative Patients in Rostov-on-DonAntibiotiki I Khimioterapiya20214
17Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic ResistanceAntibiotiki I Khimioterapiya20214
18Study of Cases of Bacteremia with Gram-Negative Pathogens with Multiple and Extreme Antibiotic Resistance in Real Clinical PracticeAntibiotiki I Khimioterapiya20214
19Possibilities of suppressing the cytopathogenic effect of SARS-CoV-2 coronavirus according to the results of the antiviral activity of Cytovir®-3 <i>in vitro</i> studyAntibiotiki I Khimioterapiya20214
20Serotype composition of Streptococcus pneumoniae in children with respiratory infections, optimization of molecular assessment methodsAntibiotiki I Khimioterapiya20224
21Comparative Activity of Carbapenem Antibiotics Against Gram-Negative Carbapenemase Producers of Different GroupsAntibiotiki I Khimioterapiya20224
22Eradication, Strain Preservation, Strain Change — Outcomes of Helicobacter pylori TherapyAntibiotiki I Khimioterapiya20213
23Comparative Effectiveness of Riamilovir and Umifenovir for Treating InfluenzaAntibiotiki I Khimioterapiya20213
24The Corrective Effect of Fucoidan, a Sulfated Polysaccharide Extracted from Brown Algae Fucus evanescens, in the Formation of a Specific Immune Response Against Seasonal Influenza Viruses in the ElderlyAntibiotiki I Khimioterapiya20203
25Antibiotic-Resistant Uropathogenic Escherichia coli Isolated from Children with Congenital Abnormalities of the Kidneys and Urinary TractAntibiotiki I Khimioterapiya20203
26Seaweed-Derived Sulfated Polysaccharides as Potential Agents for Prevention and Treatment of Influenza and COVID-19Antibiotiki I Khimioterapiya20213
27Immunogenicity, Safety, and Clinical Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Spondyloarthritis (Preliminary Data)Antibiotiki I Khimioterapiya20223
28Cytokine Storm in the Novel Coronavirus Infection and Methods of its CorrectionAntibiotiki I Khimioterapiya20212
29Features of Preoperative Preparation of Patients with Burns and Chronic Ulcers of Various Etiology for AutodermoplastyAntibiotiki I Khimioterapiya20212
30Pharmacokinetics of Pentanedioic Acid Imidazolyl Ethanamide in Healthy VolunteersAntibiotiki I Khimioterapiya20212
31Analysis of Antibiotic Resistance of Vibrio Сholerae Isolated From Environmental Objects in Russia in 2019Antibiotiki I Khimioterapiya20212
32Possibilities of Hyperinflammation Correction in COVID-19Antibiotiki I Khimioterapiya20212
33Rationale for a New Outpatient Drug Therapy Algorithm in COVID-19 Patients Based on the Principle of «Multi-hit» ApproachAntibiotiki I Khimioterapiya20212
34Meta-analysis of randomized clinical trials of Riamilovir efficacy in etiotropic therapy of influenzaAntibiotiki I Khimioterapiya20212
35Determination of the Effectiveness of Antibiotic Therapy by Conducting Therapeutic Drug MonitoringAntibiotiki I Khimioterapiya20202
36Microbial Biofilms: Modern ConceptsAntibiotiki I Khimioterapiya20202
37The Efficacy of a Peptide Product from the Pituitary Gland of <i>Rangifer tarandus</i> as an Antioxidant Agent Under the Combined Effects of Light Desynchronosis and Depriming ToxicantAntibiotiki I Khimioterapiya20212
38Antiviral Activity of Kagocel® on the Model of Experimental Lethal Influenza InfectionAntibiotiki I Khimioterapiya20202
39The Influence of Polysaccharides from Sea Algae on the Pathogenetic Targets of <i>Helicobacter Pylori</i> — a New Direction in Therapy and Prevention of InfectionAntibiotiki I Khimioterapiya20202
40Meta-analytical evaluation of the clinical efficacy of a complex metabolic neuroprotector in patients with chronic cerebral ischemiaAntibiotiki I Khimioterapiya20222
41Fluorescence Polarization Immunoassay, for Express Control of Antibiotic Levels: Design and Characteristics for Chloramphenicol, as an ExampleAntibiotiki I Khimioterapiya20162
42Evaluating Changes in The Clinical Presentation of Acute Obstructive Bronchitis in Preschool Children Using Antiviral TherapyAntibiotiki I Khimioterapiya20162
43Methods and Approaches for Antibiotics DeteсtionAntibiotiki I Khimioterapiya20222
44Mobile Genetic Elements of Prokaryotes and Their Role in the Formation of Antibiotic Resistance in Pathogenic BacteriaAntibiotiki I Khimioterapiya20222
45The Effect of Rifampicin on the Induction of MDR1/P-gp Activity in Proinflammatory Human MacrophagesAntibiotiki I Khimioterapiya20222
46Study of the Antiviral Activity of Adamantane-Containing Chemical CompoundsAntibiotiki I Khimioterapiya20222
47Modern View on Enterococcus faecalis and Enterococcus faecium Resistance Mechanisms to AntibioticsAntibiotiki I Khimioterapiya20211
48Survival Outcomes in Patients after Radical Surgery for Non-Small Lung Cancer: an 8-year Study at N. N. Blokhin Cancer Research CenterAntibiotiki I Khimioterapiya20211
49Baricitinib in the Treatment of Patients with COVID-19: A Review of International Data and Analysis of Clinical Results in the Russian PopulationAntibiotiki I Khimioterapiya20211
50Cytokine tatus in patients with recurrent herpes infectionAntibiotiki I Khimioterapiya20211